New combination treatment flips the switch on melanoma cells
Wednesday, October 24, 2018 - 11:40
in Biology & Nature
New research shows that navitoclax plus A-1210477 not only killed melanoma cells, but also killed the melanoma initiating cells (aka cancer stem cells) that often resist therapy.